An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation

Article Type
Article
Changed
Thu, 01/10/2019 - 12:14
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation
Author(s)
Cook-Bolden FE
Hamilton SF

Article PDF
081040365.pdf
Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Issue
Cutis - 81(4)
Publications
Cutis
MDedge Dermatology
Topics
Pigmentation Disorders
Page Number
365-371
Sections
Original Research
Author(s)
Cook-Bolden FE
Hamilton SF
Author(s)
Cook-Bolden FE
Hamilton SF
Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Author and Disclosure Information

Cook-Bolden FE, Hamilton SF

Article PDF
081040365.pdf
Article PDF
081040365.pdf

Issue
Cutis - 81(4)
Issue
Cutis - 81(4)
Page Number
365-371
Page Number
365-371
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Pigmentation Disorders
Article Type
Article
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation
Display Headline
An Open-Label Study of the Efficacy and Tolerability of Microencapsulated Hydroquinone 4% and Retinol 0.15% With Antioxidants for the Treatment of Hyperpigmentation
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Hamilton SF